Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $4.01 Million - $4.55 Million
-86,400 Reduced 55.42%
69,500 $3.64 Million
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $6.71 Million - $7.64 Million
151,600 Added 3525.58%
155,900 $7.19 Million
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $204,379 - $231,039
4,300
4,300 $231,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.